Novel Nanosensors for Rapid Analysis of Telomerase Activity

Elevated telomerase levels are found in many malignancies, offering an attractive target for therapeutic intervention and diagnostic or prognostic purposes. Here we describe the use of a novel nanosensor developed for rapid screens of telomerase activity in biological samples. The technique utilizes magnetic nanoparticles that, on annealing with telomerase synthesized TTAGGG repeats, switch their magnet state, a phenomenon readily detectable by magnetic readers. We tested the efficacy of different telomerase inhibitors in crude human and murine samples and show that phosphorylation of telomerase regulates its activity. High-throughput adaptation of the technique by magnetic resonance imaging allowed processing of hundreds of samples within tens of minutes at ultrahigh sensitivities. Together, these studies establish and validate a novel and powerful tool for rapidly sensing telomerase activity and provide the rationale for developing analogous magnetic nanoparticles for in vivo sensing.

[1]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[2]  Ralph Weissleder,et al.  Magnetic sensors for protease assays. , 2003, Angewandte Chemie.

[3]  A. Zeiher,et al.  Regulation of telomerase activity and anti‐apoptotic function by protein–protein interaction and phosphorylation , 2003, FEBS letters.

[4]  Hidetoshi Sato,et al.  A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance. , 2003, Nucleic acids research.

[5]  L. Gong,et al.  Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. , 2003, World journal of gastroenterology.

[6]  M. Blasco,et al.  Massive Telomere Loss Is an Early Event of DNA Damage-induced Apoptosis* , 2003, The Journal of Biological Chemistry.

[7]  M. Blasco,et al.  Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation , 2003, The EMBO journal.

[8]  Henning Wege,et al.  SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. , 2002, Nucleic acids research.

[9]  R. DePinho,et al.  Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. , 2003, Genes & development.

[10]  D. Corey,et al.  Telomerase inhibitors: a new option for chemotherapy. , 2003, Advances in cancer research.

[11]  N. Sato,et al.  Telomerase as a new target for pancreatic cancer treatment. , 2002, Journal of hepato-biliary-pancreatic surgery.

[12]  L. Chin,et al.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.

[13]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[14]  Shunqing Xu,et al.  Bioluminescent method for detecting telomerase activity. , 2002, Clinical chemistry.

[15]  L. Guillou,et al.  Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas , 2002, International journal of cancer.

[16]  Ralph Weissleder,et al.  DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. , 2002, Journal of the American Chemical Society.

[17]  A. Schnapp,et al.  A highly selective telomerase inhibitor limiting human cancer cell proliferation , 2001, The EMBO journal.

[18]  J. Kim,et al.  Protein kinase C modulates telomerase activity in human cervical cancer cells , 2001, Experimental & Molecular Medicine.

[19]  Ralph Weissleder,et al.  Magnetic Nanosensors for the Detection of Oligonucleotide Sequences. , 2001, Angewandte Chemie.

[20]  Kebin Liu,et al.  Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein But Is Associated with hTERT Phosphorylation and Nuclear Translocation , 2001, The Journal of Immunology.

[21]  Lynda Chin,et al.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice , 2000, Nature.

[22]  T. Pandita,et al.  Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase , 2000, Current Biology.

[23]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[24]  R. Weil,et al.  Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[25]  R. DePinho,et al.  A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.

[26]  K. Dhaene,et al.  Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures , 2000, British Journal of Cancer.

[27]  D. Corey,et al.  Telomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells , 1999, Oncogene.

[28]  P. Iversen,et al.  The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells. , 1999, Experimental cell research.

[29]  M. Tsuchiya,et al.  Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. , 1999, Biochemistry.

[30]  K. Shigemasa,et al.  Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines. , 1999, European journal of cancer.

[31]  S. Do,et al.  Akt Protein Kinase Enhances Human Telomerase Activity through Phosphorylation of Telomerase Reverse Transcriptase Subunit* , 1999, The Journal of Biological Chemistry.

[32]  A. Cheng,et al.  Polymerase Chain Reaction‐based Enzyme Immunoassay for Quantitation of Telomerase Activity: Application to Colorectal Cancers† , 1999, Japanese journal of cancer research : Gann.

[33]  He Li,et al.  Telomerase Is Controlled by Protein Kinase Cα in Human Breast Cancer Cells* , 1998, The Journal of Biological Chemistry.

[34]  D. Lackey.  A homogeneous chemiluminescent assay for telomerase. , 1998, Analytical biochemistry.

[35]  S. Capaccioli,et al.  Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. , 1998, Clinical chemistry.

[36]  D. Corey,et al.  Inhibition of human telomerase by 2'-O-methyl-RNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Neidle,et al.  1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.

[38]  R. Weinberg,et al.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase , 1998, Oncogene.

[39]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[40]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[41]  M. Falchetti,et al.  Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction. , 1998, Nucleic acids research.

[42]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[43]  C. Greider.  Telomerase activity, cell proliferation, and cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Li,et al.  Protein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Breast Cancer Cells* , 1997, The Journal of Biological Chemistry.

[45]  Nam W. Kim,et al.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..

[46]  P. Iversen,et al.  A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. , 1997, Toxicology and applied pharmacology.

[47]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[48]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[49]  J. Shay,et al.  Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. , 1996, Cancer research.

[50]  E. Blackburn,et al.  Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.

[51]  T. Metz,et al.  Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes , 1995, Cell.

[52]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[53]  E. Blackburn,et al.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs , 1990, Nature.

[54]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[55]  Y Nishizuka,et al.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.